Drug Use Analysis of Postoperative Chemotherapy in Patients with Non-small Cell Lung Cancer
- VernacularTitle:非小细胞肺癌术后化疗患者药物利用调查
- Author:
Yuzhou SHEN
;
Xufeng PAN
;
Heng ZHAO
- Publication Type:Journal Article
- Keywords:
Non-small cell lung cancer;
Postoperative chemotherapy;
Analysis of drug use;
Drug utilization
- From:
China Pharmacist
2014;(2):293-295
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the drug application in the postoperative chemotherapy for the patients with non-small cell lung cancer. Methods:The chemotherapy regimens, drug utilization and adverse drug reactions in the non-small cell lung cancer patients received postoperative chemotherapy in 2012 were statistically analyzed in a retrospective study. Results:Totally 8 kinds of chemother-apy regimens were used in 156 cases. The NC( vinorelbine + carboplatin) regimen was used most frequently and the PC( pemetrexed+ carboplatin) regimen was with the highest expense. Proton pump inhibitors, recombinant human erythropoietin and lentinan were the top three in the adjuvant drugs used in the treatment. Conclusion:It is necessary to further standardize the postoperative chemo-therapy for non-small cell lung cancer patients. Thoracic surgeons along with pharmacists should strengthen the drug use monitoring during the whole treatment process to promote the rational drug use.
